Accueil / Nouvelles et Évènements
Network News

GlycoNet investigators identify a cancer-associated sugar as a new biomarker for scleroderma

A sugar that’s been linked to cancer could also serve as an early indicator of severe scleroderma, improving diagnosis and treatment options for patients with ...

The Carbohydrate Connection: Finding a Way to Target Alzheimer’s 

GlycoNet Investigator Dr. Matthew Macauley is uncovering how carbohydrates influence immune cells in the brain and their impact on Alzheimer’s disease.

Strategic Science Fund Announcement

GlycoNet is grateful to be one of the inaugural recipients of the Strategic Science Fund.

Plus d'histoires

  • Tout
  • Prix
  • Communauté
  • Profil du Réseau
  • Communiqué de presse
  • Points saillants de la recherche

Registration for the 7th Canadian Glycomics Symposium and the 10th Warren Workshop is now open

Travel Awards available for HQP(Trainees, Graduate Students, Postdoctoral Fellows & Research Associates)

Cracking the Code of Cellular Health: Dr. Vocadlo’s Pioneering Research

GlycoNet Investigator’s discovery provides insight into a vital cellular process that could be leveraged to unlock new therapeutic pathways for neurodegenerative diseases and cancer.

GlycoNet welcomes four new members to the Board of Directors

Dr. Obadiah Plante, Dr. Antonia Borovina, Dr. Rika Jolie and Dr. Hamed Ghanei have joined the GlycoNet Board of Directors.

Remembering Dr. Doug Inglis: A Tribute to a Life Well-Lived

Tribute to Dr. G. Douglas Inglis by Dr. Wade Abbott.

GlycoNet releases its 2022-2023 Corporate Report

The report encapsulates a comprehensive overview of the network's achievements, breakthroughs, and collaborations in the field of glycomics throughout the past year. Within the report, ...

Senator Paula Simons gets the sweet scoop on GlycoNet and glycomics

Senator Paula Simons recently toured GlycoNet at the University of Alberta, exploring the realm of glycomics. The visit highlighted GlycoNet's pivotal role in advancing glycomics ...

GlycoNet researchers develop ‘ice inhibitors’ to protect cells during cryopreservation

New compounds could open more opportunities for vital medical treatments, organ and tissue transplants, and reproductive medicine.
Dr. Brian Ward, McGill University

Decoding sugars: Harnessing glycomics to fight infectious diseases

GlycoNet scientists are expanding our knowledge of sugars to engineer new health solutions.
Attendees at the 2023 Canadian Glycomics Symposium

Sweet science in the spotlight at the 2023 Canadian Glycomics Symposium

Over 150 top researchers, industry experts, and emerging talent in glycomics recently gathered in Edmonton, Alberta to discuss advancements and the latest trends in glycomics.

Réseau Canadien de la Glycomique
E5-33 Gunning/Lemieux Chemistry Centre
University of Alberta, T6G 2G2
Tél.: 780-492-6204
Téléc.: 780-492-4147

Inscription à la newsletter de GlycoNet

© Réseau Canadien de la Glycomique (GlycoNet). Tous droits réservés.

Remonter en haut de la page